Where is Panomics located?

Panomics is headquartered in New York City, United States.

How many employees does Panomics have?

As of Aug 31, 2026, the latest employee count at Panomics is 5.

Where does Panomics rank among its competitors?

Panomics ranks 54th amongst 115 active competitors, of which 34 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was IMU Biosciences, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of Panomics?

Panomics' top competitors include Cellworks, Geneyx and IMU Biosciences. Among them, IMU Biosciences secured the most recent funding round in June, 2026.

Panomics - 2026 Company Profile & Competitors

Company Details

Provider of multi-omics data analysis platform for drug development. It integrates genomics, transcriptomics, proteomics, and metabolomics data that enables the analysis of complex biological data sets, providing valuable insights for precision medicine, personalized healthcare, and drug discovery.

Key Metrics

Founded Year

2022

Location

New York City, United States

Stage

Unfunded

Ranked

54^th among 115 active competitors

Employee Count

5 as on Aug 31, 2026

Similar Companies

Cellworks & 134 more

View Panomics' full profile

Panomics has not raised any funding rounds yet.

Panomics' employee count trend

Panomics has 5 employees as of Aug 26. Here is Panomics's employee count trend over the years:

Uncover Panomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Panomics include Cellworks, Geneyx and IMU Biosciences. Here is the list of Top 10 competitors of Panomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cellworks 2005, San Jose (United States), Series B	Developer of a biosimulation platform	$16.5M	Bering Capital, Artiman & 4 others	67/100
2nd	Geneyx 2018, Herzliya (Israel), Seed	Provider of a clinical genetics data management platform for hospitals and genetic labs	$10M	Capri Ventures, Accenture & 5 others	57/100
3rd	IMU Biosciences 2019, London (United Kingdom), Series A	Provider of immune discovery platform for precision medicines	$53M	Molten Ventures, IQ Capital & 4 others	56/100
4th	ICarbonX 2015, Shenzhen (China), Series D	Provider of bioinformatic platforms for health management and drug development	$366M	Wealthking Investments, China Investment Corporation ... & 11 others	55/100
5th	Life Bit 2017, London (United Kingdom), Series B	AI and SaaS-based genomics analysis software for drug development	$70.9M	Tiger Global Management, Idinvest Partners ... & 13 others	54/100
6th	Biostate 2023, Houston (United States), Series A	Developer of generative AI based RNAstate research platform to predict future omics states	$16M	Accel, Catapult & 10 others	53/100
7th	NeoCura 2017, Changping (China), Series A	Provider of an AI-enabled immunotherapy based tumor diagnostic platform	$38.2M	CDH, PICC Capital Investment Management & 5 others	52/100
8th	Watershed 2019, Sacramento (United States), Series A	Provider of software solution for biological data analysis, discovery, and collaboration	$19.7M	Canvas Ventures, Accomplice & 3 others	48/100
9th	Liquid Biosciences 2017, Aliso Viejo (United States), Series C	Provider of bio-analytics platform to identify the biological and behavioral truth driving patient outcomes	$40.1M	-	48/100
10th	ROSALIND 2013, San Diego (United States), Seed	Cloud-based collaborative bioinformatics platform for researchers	$70K	Tech Coast Angels, Wavemaker 360 & 2 others	45/100
54th	Panomics 2022, New York City (United States), Unfunded	Provider of multi-omics data analysis platform for drug development	-	-	25/100